Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal royal jelly versus vaginal Premarin for quality of life in menopausal women with vaginal atrophy
IRCT2014112220043N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of conjugated estrogens in vaginal atrophy and menopause (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Quality of life. Started Sep 2013; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
vaginal atrophymenopause
Beyond the preview
Go deeper on IRCT2014112220043N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014112220043N1.